MaxCyte, Inc.
MXCT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $6,829 | $8,507 | $10,390 | $8,693 |
| % Growth | -19.7% | -18.1% | 19.5% | – |
| Cost of Goods Sold | $516 | $1,519 | $1,497 | $2,281 |
| Gross Profit | $6,313 | $6,988 | $8,893 | $6,412 |
| % Margin | 92.4% | 82.1% | 85.6% | 73.8% |
| R&D Expenses | $5,316 | $6,269 | $5,903 | $4,614 |
| G&A Expenses | $6,028 | $8,080 | $8,526 | $7,206 |
| SG&A Expenses | $9,938 | $13,866 | $14,224 | $13,679 |
| Sales & Mktg Exp. | $3,936 | $5,786 | $5,698 | $6,473 |
| Other Operating Expenses | $1,631 | $1,080 | $1,061 | $1,020 |
| Operating Expenses | $16,885 | $21,215 | $21,188 | $19,313 |
| Operating Income | -$10,572 | -$14,227 | -$12,295 | -$12,901 |
| % Margin | -154.8% | -167.2% | -118.3% | -148.4% |
| Other Income/Exp. Net | -$1,844 | $1,870 | $2,034 | $2,304 |
| Pre-Tax Income | -$12,416 | -$12,357 | -$10,261 | -$10,597 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$12,416 | -$12,357 | -$10,261 | -$10,597 |
| % Margin | -181.8% | -145.3% | -98.8% | -121.9% |
| EPS | -0.12 | -0.12 | -0.1 | -0.1 |
| % Growth | 0% | -20% | 0% | – |
| EPS Diluted | -0.12 | -0.12 | -0.1 | -0.1 |
| Weighted Avg Shares Out | 106,325 | 106,404 | 105,950 | 104,849 |
| Weighted Avg Shares Out Dil | 106,325 | 106,404 | 105,950 | 104,849 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,733 | $1,870 | $2,034 | $2,304 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $848 | $1,297 | $1,277 | $1,532 |
| EBITDA | -$11,568 | -$12,930 | -$11,018 | -$11,369 |
| % Margin | -169.4% | -152% | -106% | -130.8% |